Search

everythinglearnresearchcommunity

for

Search:↓

Smart microneedles using advanced tech could improve psoriasis treatment.

Melanocytes can regenerate around hair follicles in bullous pemphigoid, especially in patients with darker skin.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Skin symptoms can indicate endocrine disorders and have various treatments.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

People with alopecia areata have higher insulin resistance.

A substance from hair follicle stem cells helps heal skin wounds in diabetic mice by promoting cell growth and preventing cell death.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

CBD can either promote or inhibit hair growth depending on the concentration used.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Pluripotent stem cells show promise for treating skin color loss disorders like vitiligo.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Human hair follicles have a scent receptor that can influence hair growth.